胶质母细胞瘤局限野放疗期间中期MRI变化评估及其对治疗计划的意义
本研究利用科室MRI模拟机对接受局限野放疗的幕上胶质母细胞瘤患者在放疗前和放疗中行MRI,比较GTV变化。结果显示初始CTV外扩15 mm、推量CTV外扩7 mm是合理方案,GTV勾画时常规省略T2异常可能不影响疾病控制。
要点
- 初始CTV外扩15 mm、推量CTV外扩7 mm是GBM局限野放疗的合理方案。
- GTV勾画时常规省略T2异常可能不危及疾病控制。
- 24%患者基于中期MRI重新计划,多数GTV2可被GTV1+7 mm覆盖。
核心结论
- 初始CTV外扩15 mm后推量CTV外扩7 mm是GBM局限野放疗的合理方法。
- GTV勾画中常规不纳入T2异常可能不会危及疾病控制。
研究设计与样本
- 接受局限野放疗(46 Gy+推量至60 Gy)的幕上GBM患者行基线MRI(MRI1)和放疗中MRI(MRI2)。
- 2014-2019年共治疗120例患者,其中29例(24%)基于MRI2重新计划。
- GTV1定义为MRI1上T1强化+手术腔,不常规纳入T2异常(除非肿瘤无强化)。
- 初始CTV外扩为GTV1外15 mm,推量CTV外扩为5-7 mm。
- GTV1特征分为三组:A组T1与T2异常一致,B组仅有T1异常且较大T2异常未纳入,C组肿瘤无强化时的T2异常。
主要发现
- MRI2上84%的GTV2被GTV1+5 mm覆盖,93%被GTV1+7 mm覆盖,98%被GTV1+15 mm覆盖。
- MRI1上43%的GTV1可归为A组,39%为B组,18%为C组。
- B组的失败模式、局部控制或PFS与A/C组相似。
关键数值与推荐
- 初始CTV外扩15 mm,推量CTV外扩7 mm。
- GTV1定义为T1强化+手术腔,不常规纳入T2异常(除非肿瘤无强化)。
- GTV1+5 mm覆盖84%的GTV2,GTV1+7 mm覆盖93%,GTV1+15 mm覆盖98%。
临床怎么用
- 局限野放疗可采用初始CTV外扩15 mm、推量CTV外扩7 mm的方案。
- GTV勾画时可考虑不常规纳入T2异常,但需注意肿瘤无强化时纳入T2异常。
- 放疗中MRI变化可指导重新计划,本研究中24%患者基于MRI2重新计划。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: Consensus for defining gross tumor volume (GTV) and clinical target volume (CTV) for limited-field radiation therapy (LFRT) of GBM are not well established. We leveraged a department MRI simulator to image patients before and during LFRT to address these questions. MATERIALS AND METHODS: Supratentorial GBM patients receiving LFRT (46 Gy + boost to 60 Gy) underwent baseline MRI (MRI1) and interim MRI during RT (MRI2). GTV1 was defined as T1 enhancement + surgical cavity on MRI1 without routine inclusion of T2 abnormality (unless tumor did not enhance). The initial CTV margin was 15 mm from GTV1, and the boost CTV margin was 5-7 mm. The GTV1 characteristics were categorized into three groups: identical T1 and T2 abnormality (Group A), T1 only with larger T2 abnormality not included (Group B), and T2 abnormality when tumor lacked enhancement (Group C). GTV2 was contoured on MRI2 and compared with GTV1 plus 5-15 mm expansions. RESULTS: Among 120 patients treated from 2014-2019, 29 patients (24%) underwent replanning based on MRI2. On MRI2, 84% of GTV2 were covered by GTV1 + 5 mm, 93% by GTV1 + 7 mm, and 98% by GTV1 + 15 mm. On MRI1, 43% of GTV1 could be categorized into Group A, 39% Group B, and 18% Group C. Group B's patterns of failure, local control, or progression-free survival were similar to Group A/C. CONCLUSIONS: Initial CTV margin of 15 mm followed by a boost CTV margin of 7 mm is a reasonable approach for LFRT of GBM. Omitting routine inclusion of T2 abnormality from GTV delineation may not jeopardize disease control.
引用
- Hassanzadeh C, Rudra S, Ma S, et al. Evaluation of interim MRI changes during limited-field radiation therapy for glioblastoma and implications for treatment planning. Radiother Oncol. 2021. PMID: 33587967. doi:10.1016/j.radonc.2021.01.040
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。